GlassScriptPhysician profile
John T Norman
NPI 1790878692
$1,466.44
in general payments reported to CMS, 2019-2025
15 companies · $81.19 in 2025
The $81.19 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $88.89 · 2021: $237 · 2022: $205 · 2023: $204 · 2024: $168 · 2025: $81.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $630.93 | 2019-2025 | Mako |
| Osteoremedies, LLC | $389.59 | 2019-2023 | Remedy Spacer |
| Alpha Orthopedic Systems | $169.72 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $38.66 | 2024-2025 | Exparel, Zilretta, Iovera |
| Pacira Therapeutics, INC. | $34.69 | 2020 | |
| Smith+Nephew, INC. | $32.54 | 2022 | |
| Amgen INC. | $29.47 | 2019 | |
| Linvatec Corporation | $25.94 | 2023 | Allograft Tissue |
| Vericel Corporation | $22.74 | 2019 | |
| Abbvie INC. | $18.66 | 2024 | |
| Molnlycke Health Care US, LLC | $18.00 | 2025 | Avance, Mepilex Border Post-Op Ag |
| Medtronic, INC. | $17.90 | 2023 | Kyphon Express II Kyphopak Tray |
| Avanos Medical | $14.74 | 2019 | |
| Paragon 28, INC. | $12.95 | 2020 | |
| Orthofix Medical, INC. | $9.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Norman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.